AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Panayiotidis Panayiotis

Panayiotidis Panayiotis

National and Kapodistrian University of Athens - Athens / Greece
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1845786
Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
person_outline Panayiotidis Panayiotis's MOST POPULAR ARTICLES
1-) Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial Blood, The Journal of the American Society of Hematology 135 (24), 2137-2145, 2020
2-) Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial The Lancet Oncology 19 (6), 747-757, 2018
3-) Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic … The Lancet Oncology 17 (2), 200-211, 2016
4-) Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma Journal of Clinical Oncology 35 (35), 3898-3905, 2017
5-) Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic … European journal of immunology 26 (2), 294-299, 1996